AI assistant
Sending…
Neurogene Inc. — Director's Dealing 2015
Feb 26, 2015
33497_dirs_2015-02-26_efd1c2a3-aa3d-4216-824e-1b5e2c9b7877.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AQUINOX PHARMACEUTICALS, INC (AQXP)
CIK: 0001404644
Period of Report: 2015-02-16
Reporting Person: Nolan Sean P. (Director)
More from Neurogene Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Regulatory Filings
2026
May 12
Board/Management Information
2026
Apr 20
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Earnings Release
2026
Mar 24
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 26